Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 4,172 | 791 | 771 | 855 | 268 |
| Gross Profit | 4,172 | 791 | 771 | 855 | 268 |
| Operating Expenses | 41,456 | 35,580 | 35,526 | 32,164 | 44,030 |
| Operating Income | -37,284 | -34,789 | -34,755 | -31,309 | -43,762 |
| Other Income | 2,988 | 3,555 | 3,570 | 3,248 | 3,495 |
| Pre-tax Income | -34,296 | -31,234 | -31,185 | -28,061 | -40,267 |
| Income Tax | 1,775 | -8 | 22 | 1 | -869 |
| Net Income Continuous | -36,071 | -31,226 | -31,207 | -28,062 | -39,398 |
| Net Income | $-36,071 | $-31,226 | $-31,207 | $-28,062 | $-39,398 |
| EPS Basic Total Ops | -0.41 | -0.37 | -0.38 | -0.45 | -0.66 |
| EPS Basic Continuous Ops | -0.41 | -0.37 | -0.38 | -0.45 | -0.66 |
| EPS Diluted Total Ops | -0.41 | -0.37 | -0.38 | -0.45 | -0.66 |
| EPS Diluted Continuous Ops | -0.41 | -0.37 | -0.38 | -0.45 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.37 | -0.38 | -0.45 | N/A |
| EBITDA(a) | $-34,999 | $-32,812 | $-32,636 | $-29,198 | $-44,194 |